Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

7792 ARTÍCULOS , VIENDO DEL 5056 AL 5070

Levodopa-induced dyskinesia in Parkinson's disease: an updated review of pharmacological treatments

Chen F, Zhou C.

Front Aging Neurosci. 2025 Oct 21;17:1684885. doi: 10.3389/fnagi.2025.1684885. eCollection 2025.

Immunotherapy in Early Parkinson's Disease: A Biomarker-Driven Trial Framework for Secondary Prevention

Kniazev R.

Cureus. 2025 Nov 4;17(11):e96090. doi: 10.7759/cureus.96090. eCollection 2025 Nov.

Stochastic resonance stimulation effect on stability during walking in people with Parkinson disease

Alsaqabi E, DiBianca S, Sansare A, Verma K, Reimann H, Jeka J.

Int Biomech. 2025 Dec;12(1):81-94. doi: 10.1080/23335432.2025.2584665. Epub 2025 Nov 6.

Gut-brain communication: nerve circuits and chemical messengers of colorectal motility and defecation control

Han MN, Furness JB, Ringuet MT, Montenegro E, Wu H, Hossain MA, Diwakarla S, Dehkhoda F, Furness SGB.

Am J Physiol Regul Integr Comp Physiol. 2025 Dec 1;329(6):R931-R945. doi: 10.1152/ajpregu.00212.2025. Epub 2025 Nov 6.

Can table tennis protect the aging brain? A systematic review and meta-analysis in neurodegenerative diseases

Łosińska K, Maszczyk A.

Acta Psychol (Amst). 2025 Nov;261:105884. doi: 10.1016/j.actpsy.2025.105884. Epub 2025 Nov 5.

Integrating Palliative Care in Parkinson's Disease and Related Disorders: A Systematic Review of Patient and Caregiver Outcomes

Barros-Ferreira MI, Reis-Pina P.

Am J Hosp Palliat Care. 2025 Nov 6:10499091251393691. doi: 10.1177/10499091251393691. Online ahead of print.

Synergy between stem cell therapy and brain-derived neurotrophic factor (BDNF) in Parkinson's disease: a mini-review of combined neuroregenerative strategies

Jonny J, Larasati AD, Sunjaya QA, Faried A.

Chin Neurosurg J. 2025 Nov 6;11(1):29. doi: 10.1186/s41016-025-00415-5.

Incidence and factors associated with postoperative delirium after primary total joint arthroplasty in older adults: a systematic review and meta-analysis

Ni Y, Yang X, Yang Y, Zhang H, Peng S.

Front Med (Lausanne). 2025 Oct 22;12:1664605. doi: 10.3389/fmed.2025.1664605. eCollection 2025.

Editorial: Myeloid cells as active players in human neurodegenerative diseases

Iyer AK, Moutinho M, Ayata P, Karahan H.

Front Neurosci. 2025 Oct 22;19:1712394. doi: 10.3389/fnins.2025.1712394. eCollection 2025.

Extracellular Matrix (ECM)-Regulated Molecular Switches: Tissue Inhibitors of Metalloproteinases in Synaptic Formation and Neuropathic Diseases

Qi S, Wang S, Tan Y, Pan C, Bi X.

Cell Mol Neurobiol. 2025 Nov 7;45(1):100. doi: 10.1007/s10571-025-01621-6.

The ketogenic diet in Parkinson's disease: a potential therapeutic strategy

Pokora B, Pokora K, Binienda A, Fichna J.

Pharmacol Rep. 2025 Dec;77(6):1491-1513. doi: 10.1007/s43440-025-00799-2. Epub 2025 Nov 7.

Rethinking neurodegeneration through a co-proteinopathy lens

Zhang YP, Kedia S, Klenerman D.

Trends Neurosci. 2025 Dec;48(12):952-963. doi: 10.1016/j.tins.2025.10.006. Epub 2025 Nov 6.

Are we ready for a biological diagnosis of Parkinson's Disease?

Cimmino AT, Di Lazzaro G, Pisani A, Bentivoglio AR, Calabresi P.

Cell Death Dis. 2025 Nov 7;16(1):808. doi: 10.1038/s41419-025-08076-z.

Author Correction: Integrating digital gait data with metabolomics and clinical data to predict outcomes in Parkinson's disease

Brzenczek C, Klopfenstein Q, Hähnel T, Sapienza S, Klucken J, Fröhlich H, Glaab E; NCER-PD Consortium.

NPJ Digit Med. 2025 Nov 7;8(1):645. doi: 10.1038/s41746-025-02098-9.

Deubiquitinating enzymes in parkinson's disease: molecular mechanisms and therapeutic potential

Wu Y, Deng Y, Ai Q, Li Y, Qin F, Hammad M, Meng Z, Xu X, Wei J, Yu H, Liang G, Zhao X.

Mol Med. 2025 Nov 7;31(1):329. doi: 10.1186/s10020-025-01389-x.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias